In support of LRP2’s role in cancer, Andersen et al., have reported that LRP2 is more frequently expressed among malignant melanoma samples compared with benign counterparts and that the proliferation and survival rates of cultured LRP2-expressing melanoma cells decrease upon the siRNA-mediated knockdown of LRP2 [7]. Here, LRP2 is linked to cancer.